Berdel, Wolfgang E., 1952-
Berdel, Wolfgang E.
Wolfgang E. Berdel německý lékař a vysokoškolský pedagog zaměřený na leukémii, krvetvorné kmenové buňky, alogenní buněčnou terapii, lymfon, mnohočetný myelom, psychoonkologii a nádorovou angiogenezi
VIAF ID: 20248350 ( Personal )
Permalink: http://viaf.org/viaf/20248350
Preferred Forms
- 100 1 _ ‡a Berdel, Wolfgang E
- 100 1 _ ‡a Berdel, Wolfgang E.
- 100 1 _ ‡a Berdel, Wolfgang E.
- 100 1 _ ‡a Berdel, Wolfgang E.
-
-
-
- 100 1 _ ‡a Berdel, Wolfgang E. ‡d 1952-
-
- 100 0 _ ‡a Wolfgang E. Berdel ‡c německý lékař a vysokoškolský pedagog zaměřený na leukémii, krvetvorné kmenové buňky, alogenní buněčnou terapii, lymfon, mnohočetný myelom, psychoonkologii a nádorovou angiogenezi
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome | |
Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases | |
Angiogenesis inhibition | |
Antineoplastische Wirkung von Äther-Lipid-Derivaten experimentelle Ergebnisse u. 1. klin. Erfahrungen mit Alkyl-Lysophospholipid-Derivaten u.a. Äther-Lipid-Derivaten | |
Chirurgische Behandlung akuter Ischämie der oberen Extremität | |
Contributions of the Conference "Interdisciplinary Treatment of Lung Cancer" March 2 - 3, 2001, Münster, Germany | |
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study | |
Endomucin-Expression und -Stammzellfunktionalität in Hämatopoese und Leukämie | |
Ether lipids in oncology : proceedings of the First International Symposium on Ether Lipids in Oncology held in Göttingen, Federal Republic of Germany, December 5-7, 1986 | |
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma | |
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials | |
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV | |
Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects | |
Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia | |
Kompendium internistische Onkologie | |
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis | |
Maintenance of Leukemia-Initiating Cells Is Regulated by the CDK Inhibitor Inca1 | |
Metastasierung des [Lewis-Lungenkarzinoms] (3-LL [LL]) unter dem Einfluss von Lysophospholipiden und Lysophospholipid-aktivierten Makrophagen | |
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction | |
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups | |
Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases | |
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia | |
Progressive multifocal leukoencephalopathy after ibrutinib therapy for chronic lymphocytic leukemia | |
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer | |
Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions | |
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma | |
Repetitorium Innere Medizin mit 342 Tabellen | |
Spezifische Tumortherapie durch Rezeptorvermittelte RNA Interferenz | |
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision | |
Titanocendichlorid Stand der präklinischen und klinischen Entwicklung eines neuen Zytostatikums ; 12 Tabellen | |
Transplantation in hematology and oncology II, c2002: |